Extendicare Inc. (TSE:EXE – Get Free Report) declared a monthly dividend on Friday, January 31st,TickerTech Dividends reports. Shareholders of record on Friday, February 14th will be given a dividend of 0.04 per share on Friday, February 14th. This represents a $0.48 annualized dividend and a yield of 4.59%. The ex-dividend date of this dividend is Friday, January 31st.
Extendicare Stock Up 0.9 %
Shares of TSE EXE opened at C$10.46 on Wednesday. The company has a market capitalization of C$873.10 million, a P/E ratio of 15.38 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. The company has a 50 day simple moving average of C$10.35 and a 200-day simple moving average of C$9.16. Extendicare has a 1 year low of C$6.63 and a 1 year high of C$10.89.
Extendicare (TSE:EXE – Get Free Report) last posted its earnings results on Tuesday, November 12th. The company reported C$0.19 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. During the same quarter in the previous year, the business earned $0.13 earnings per share. On average, equities research analysts predict that Extendicare will post 0.6134729 earnings per share for the current year.
Analyst Ratings Changes
View Our Latest Research Report on EXE
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Recommended Stories
- Five stocks we like better than Extendicare
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- 3 Steel Stocks Soaring After Tariff Announcements
- How to Choose Top Rated Stocks
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- When to Sell a Stock for Profit or Loss
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.